Tirzepatide generally produces greater average weight loss than semaglutide in obesity trials, but the correct comparison uses obesity brands and doses, not casual brand substitution.
Tirzepatide generally produces greater average weight loss than semaglutide in obesity trials, but the correct comparison uses obesity brands and doses, not casual brand substitution.